Whey Protein Sodium-Caseinate as a Deliverable Vector for EGCG: In Vitro Optimization of Its Bioaccessibility, Bioavailability, and Bioactivity Mode of Actions
Abstract
Share and Cite
Korin, A.; Gouda, M.M.; Youssef, M.; Elsharkawy, E.; Albahi, A.; Zhan, F.; Sobhy, R.; Li, B. Whey Protein Sodium-Caseinate as a Deliverable Vector for EGCG: In Vitro Optimization of Its Bioaccessibility, Bioavailability, and Bioactivity Mode of Actions. Molecules 2024, 29, 2588. https://doi.org/10.3390/molecules29112588
Korin A, Gouda MM, Youssef M, Elsharkawy E, Albahi A, Zhan F, Sobhy R, Li B. Whey Protein Sodium-Caseinate as a Deliverable Vector for EGCG: In Vitro Optimization of Its Bioaccessibility, Bioavailability, and Bioactivity Mode of Actions. Molecules. 2024; 29(11):2588. https://doi.org/10.3390/molecules29112588
Chicago/Turabian StyleKorin, Ali, Mostafa M. Gouda, Mahmoud Youssef, Eman Elsharkawy, Amgad Albahi, Fuchao Zhan, Remah Sobhy, and Bin Li. 2024. "Whey Protein Sodium-Caseinate as a Deliverable Vector for EGCG: In Vitro Optimization of Its Bioaccessibility, Bioavailability, and Bioactivity Mode of Actions" Molecules 29, no. 11: 2588. https://doi.org/10.3390/molecules29112588
APA StyleKorin, A., Gouda, M. M., Youssef, M., Elsharkawy, E., Albahi, A., Zhan, F., Sobhy, R., & Li, B. (2024). Whey Protein Sodium-Caseinate as a Deliverable Vector for EGCG: In Vitro Optimization of Its Bioaccessibility, Bioavailability, and Bioactivity Mode of Actions. Molecules, 29(11), 2588. https://doi.org/10.3390/molecules29112588

